Hemi- and Homozygous Loss-of-Function Mutations in DSG2 (Desmoglein-2) Cause Recessive Arrhythmogenic Cardiomyopathy with an Early Onset

Int J Mol Sci. 2021 Apr 6;22(7):3786. doi: 10.3390/ijms22073786.

Abstract

About 50% of patients with arrhythmogenic cardiomyopathy (ACM) carry a pathogenic or likely pathogenic mutation in the desmosomal genes. However, there is a significant number of patients without positive familial anamnesis. Therefore, the molecular reasons for ACM in these patients are frequently unknown and a genetic contribution might be underestimated. Here, we used a next-generation sequencing (NGS) approach and in addition single nucleotide polymor-phism (SNP) arrays for the genetic analysis of two independent index patients without familial medical history. Of note, this genetic strategy revealed a homozygous splice site mutation (DSG2-c.378+1G>T) in the first patient and a nonsense mutation (DSG2-p.L772X) in combination with a large deletion in DSG2 in the second one. In conclusion, a recessive inheritance pattern is likely for both cases, which might contribute to the hidden medical history in both families. This is the first report about these novel loss-of-function mutations in DSG2 that have not been previously identi-fied. Therefore, we suggest performing deep genetic analyses using NGS in combination with SNP arrays also for ACM index patients without obvious familial medical history. In the future, this finding might has relevance for the genetic counseling of similar cases.

Keywords: ACM; ARVC; DSC2; DSG2; LVNC; cardiomyopathy; desmin; desmocollin-2; desmoglein-2; desmosomes.

Publication types

  • Case Reports

MeSH terms

  • Arrhythmogenic Right Ventricular Dysplasia / diagnostic imaging
  • Arrhythmogenic Right Ventricular Dysplasia / genetics*
  • Desmoglein 2 / genetics*
  • Female
  • Hemizygote*
  • Homozygote*
  • Humans
  • Loss of Function Mutation*
  • Male
  • Polymorphism, Single Nucleotide*

Substances

  • DSG2 protein, human
  • Desmoglein 2